vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and POWER SOLUTIONS INTERNATIONAL, INC. (PSIX). Click either name above to swap in a different company.

POWER SOLUTIONS INTERNATIONAL, INC. is the larger business by last-quarter revenue ($191.2M vs $191.2M, roughly 1.0× Axsome Therapeutics, Inc.). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (57.4% vs 32.5%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (48.1% CAGR vs 41.7%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.

AXSM vs PSIX — Head-to-Head

Bigger by revenue
PSIX
PSIX
1.0× larger
PSIX
$191.2M
$191.2M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+24.9% gap
AXSM
57.4%
32.5%
PSIX
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
48.1%
41.7%
PSIX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXSM
AXSM
PSIX
PSIX
Revenue
$191.2M
$191.2M
Net Profit
$16.1M
Gross Margin
21.9%
Operating Margin
-33.1%
12.7%
Net Margin
8.4%
Revenue YoY
57.4%
32.5%
Net Profit YoY
-31.0%
EPS (diluted)
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
PSIX
PSIX
Q1 26
$191.2M
Q4 25
$196.0M
$191.2M
Q3 25
$171.0M
$203.8M
Q2 25
$150.0M
$191.9M
Q1 25
$121.5M
$135.4M
Q4 24
$118.8M
$144.3M
Q3 24
$104.8M
$125.8M
Q2 24
$87.2M
$110.6M
Net Profit
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
$-28.6M
$16.1M
Q3 25
$-47.2M
$27.6M
Q2 25
$-48.0M
$51.2M
Q1 25
$-59.4M
$19.1M
Q4 24
$-74.9M
$23.3M
Q3 24
$-64.6M
$17.3M
Q2 24
$-79.3M
$21.5M
Gross Margin
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
21.9%
Q3 25
23.9%
Q2 25
28.2%
Q1 25
29.7%
Q4 24
29.9%
Q3 24
28.9%
Q2 24
31.8%
Operating Margin
AXSM
AXSM
PSIX
PSIX
Q1 26
-33.1%
Q4 25
-13.8%
12.7%
Q3 25
-27.0%
13.9%
Q2 25
-24.5%
16.9%
Q1 25
-46.9%
18.2%
Q4 24
-61.1%
17.5%
Q3 24
-59.8%
16.3%
Q2 24
-89.5%
22.9%
Net Margin
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
-14.6%
8.4%
Q3 25
-27.6%
13.5%
Q2 25
-32.0%
26.7%
Q1 25
-48.9%
14.1%
Q4 24
-63.1%
16.1%
Q3 24
-61.7%
13.8%
Q2 24
-91.0%
19.5%
EPS (diluted)
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
$-0.55
$0.69
Q3 25
$-0.94
$1.20
Q2 25
$-0.97
$2.22
Q1 25
$-1.22
$0.83
Q4 24
$-1.54
$1.01
Q3 24
$-1.34
$0.75
Q2 24
$-1.67
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
PSIX
PSIX
Cash + ST InvestmentsLiquidity on hand
$305.1M
$41.3M
Total DebtLower is stronger
$70.0M
$96.6M
Stockholders' EquityBook value
$178.6M
Total Assets
$713.6M
$424.7M
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
PSIX
PSIX
Q1 26
$305.1M
Q4 25
$322.9M
$41.3M
Q3 25
$325.3M
$49.0M
Q2 25
$303.0M
$49.5M
Q1 25
$300.9M
$50.0M
Q4 24
$315.4M
$55.3M
Q3 24
$327.3M
$40.5M
Q2 24
$315.7M
$28.8M
Total Debt
AXSM
AXSM
PSIX
PSIX
Q1 26
$70.0M
Q4 25
$96.6M
Q3 25
$96.7M
Q2 25
$1.8M
Q1 25
$1.0M
Q4 24
$184.0K
Q3 24
$238.0K
Q2 24
$292.0K
Stockholders' Equity
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
$88.3M
$178.6M
Q3 25
$73.7M
$162.5M
Q2 25
$73.1M
$135.7M
Q1 25
$53.2M
$84.3M
Q4 24
$57.0M
$65.3M
Q3 24
$92.9M
$42.1M
Q2 24
$102.9M
$24.8M
Total Assets
AXSM
AXSM
PSIX
PSIX
Q1 26
$713.6M
Q4 25
$689.8M
$424.7M
Q3 25
$669.3M
$458.9M
Q2 25
$639.8M
$437.7M
Q1 25
$596.7M
$372.7M
Q4 24
$568.5M
$328.2M
Q3 24
$561.5M
$339.1M
Q2 24
$548.2M
$307.6M
Debt / Equity
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
0.54×
Q3 25
0.60×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.00×
Q3 24
0.01×
Q2 24
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
PSIX
PSIX
Operating Cash FlowLast quarter
$-4.6M
Free Cash FlowOCF − Capex
$-7.6M
FCF MarginFCF / Revenue
-4.0%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
$-18.7M
$-4.6M
Q3 25
$1.0M
$3.3M
Q2 25
$-32.4M
$16.7M
Q1 25
$-43.4M
$8.8M
Q4 24
$-26.2M
$32.7M
Q3 24
$-18.6M
$12.6M
Q2 24
$-30.1M
$1.5M
Free Cash Flow
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
$-18.7M
$-7.6M
Q3 25
$988.0K
$1.7M
Q2 25
$-32.4M
$14.6M
Q1 25
$-43.7M
$5.4M
Q4 24
$-26.2M
$30.0M
Q3 24
$-18.7M
$12.1M
Q2 24
$-30.2M
$822.0K
FCF Margin
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
-9.6%
-4.0%
Q3 25
0.6%
0.8%
Q2 25
-21.6%
7.6%
Q1 25
-36.0%
4.0%
Q4 24
-22.1%
20.8%
Q3 24
-17.9%
9.7%
Q2 24
-34.6%
0.7%
Capex Intensity
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
0.0%
1.6%
Q3 25
0.0%
0.8%
Q2 25
0.0%
1.1%
Q1 25
0.3%
2.5%
Q4 24
0.0%
1.8%
Q3 24
0.1%
0.3%
Q2 24
0.1%
0.6%
Cash Conversion
AXSM
AXSM
PSIX
PSIX
Q1 26
Q4 25
-0.29×
Q3 25
0.12×
Q2 25
0.33×
Q1 25
0.46×
Q4 24
1.40×
Q3 24
0.73×
Q2 24
0.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Product sales, net$189.4M99%
Royalty revenue and milestone revenue$1.8M1%

PSIX
PSIX

Energy End Market$153.4M80%
Industrial End Market$33.3M17%
Transportation End Market$4.6M2%

Related Comparisons